Scouting report · HELP

Greg Cavers

Chief Financial Officer, HELP since 2020-11src

CFO of Cybin/Helus Pharma since the November 2020 listing

D49 / 100

Ranked #23 of 23

Scouting sheet

as of 24 Sep 2026

Delivers guidance640 beat · 4 met · 0 missed · 1 withdrawn

Answers the question—no call reviewed yet

Capital allocation60company five-year record: neutral

Pay design10individual, time only · company lost money

Skin in the game33stake worth $260k, 0.2× last year's pay

Age: 56src
In the role: 6 yr
Promises scored: 5
Hit rate: 80%
Dodges / 100 answers: —
Airtime on calls: —

Every promise, oldest firstMMMMW··

What to weigh

Watch 2

Owns 18,987 shares (0.03%) excluding 83,334 unvested RSUs, the smallest direct stake of the listed officers, after almost six years as CFO; the company has no formal ownership guidelinesrc
Came from the CFO chair of a CSE-listed company under a cease-trade order for missed filings (LottoGopher); the order predates himsrc

In their favour 1

Continuity: the FY2026 CFO certification and the written milestone record in the dossier's S8 were signed under himsrc

Career

2020-11 – now
Cybin Inc. (Helus Pharma)src
Chief Financial Officer
Signed the 2021 Form 40-F registration as CFO (40FR12B-2021) and certifies the FY2026 annual filing (CERT-CFO-FY26); has served under every CEO and interim CEO since, from founding CEO Paul Glavine to Michael Halstead
2019-02 – 2020-01
LottoGopher Holdings Inc. (CSE)src
Chief Financial Officer and director (described in the AIF as interim CFO)
End date January 2020 from AIF-FY26

Undated in the sources

CST Industries; Scotiabank; TD; CIBCsrc, VP Finance (CST Industries); Senior Manager Enterprise Functions (Scotiabank); Private Investment Advisor (TD); Retail Small Business Lending Controller and Director of Merchant Banking Finance (CIBC)

Not located: Everything before February 2019 is undated: the bank and CST Industries roles come only from a search summary of his own LinkedIn profile, and no Cybin filing read gives his pre-2020 career

Achievements

CFO since the November 2020 reverse takeover; signed the 2021 US listing registration and every annual filing sincesrc
Stayed CFO through three CEO changes between September 2025 and August 2026src
FY2026 total pay $1.22m, his largest year in the three disclosedsrc

Education

Not stated, CA (Chartered Accountant designation)src

Background

Regulatory Interim CFO of LottoGopher Holdings until January 2020; LottoGopher had been cease-traded on 2018-12-05 for failing to file interim financials, MD&A and certifications, before he took the rolesrc
Other Employment agreement gives 12 months' notice on termination without cause plus one month per completed year of servicesrc

Pay

Salary and otherBonus, stock, options, incentive

2024$632k
2025$1.2m
2026$1.2m

The table

Year	Salary	Bonus	Stock	Options	Incentive	Other	Total
2024	$197k	$0	$0	$309k	$126k	$0	$632k	src
2025	$350k	$0	$0	$546k	$301k	$0	$1.2m	src
2026	$375k	$0	$598k	$0	$225k	$19k	$1.2m	src

Bonus pays on: Discretionary cash bonus against objectives the Compensation Committee sets each year; $225,000 paid for FY2026
Long-term award pays on: RSU grant ($598,000 in FY2026) with no performance condition disclosed; earlier years in optionssrc

Pay at risk not on file
Pays on returns individual, time only
Shareholder vote not on file
Pay vs profit company lost money

What they own

$260k at the last price on file — 0× last year's pay
18,987 shares of HELP · 0.03% of the companysrc
as of 2026-06-29

The promise ledger

5 scored · 2 open

Result	What was promised	Where it is scored	How
M Met	Repay indebtedness — $22,765 out of the October 2025 offering	HELP row 1	written outlook
M Met	Initiate enrollment in EMBRACE — $1,196	HELP row 2	written outlook
M Met	Complete the Phase 2 GAD study — $1,292	HELP row 3	written outlook
M Met	Provide topline data from the Phase 2 GAD study — $810	HELP row 4	written outlook
W Withdrawn	❗ HLP005 — deliver a drug development candidate by Q4 2026	HELP row 5	written outlook
· Still open	APPROACH topline efficacy readout in Q4 2026 (~$49,857 total, $23,686 remaining at 2026-03-31)	HELP row 6	written outlook
· Still open	HLP004 — complete the design of the next study by the end of Q3 2026 (~$150, none spent at 2026-03-31)	HELP row 7	written outlook

Sources

Filing Cybin Inc. Annual Information Form for the year ended 2026-03-31, dated 2026-06-29 (Ex-99.1 to 40-F, acc 0001833141-26-000046) · 2026-06-29
Filing Cybin Inc. management information circular for the 2026 annual and special meeting, dated 2026-08-18 (Ex-99 to 6-K, acc 0001833141-26-000067) · 2026-08-18
Filing Cybin Inc. audited consolidated financial statements FY ended 2026-03-31 (Ex-99.2 to 40-F, acc 0001833141-26-000046) · 2026-06-29
Filing Cybin Inc. 40-F FY2026, Ex-99.5 CFO certification signed by Greg Cavers · 2026-06-29
Filing Cybin Inc. Form 40-F registration statement, signed by Greg Cavers as CFO (acc 0001193125-21-224423) · 2021-07-26
Web search result WebSearch: LottoGopher Holdings announces board and management update (Newsfile, 2019-02-13): Cavers appointed director and CFO · 2026-09-24
Web search result WebSearch: Greg Cavers CA., LinkedIn profile as summarised by the search tool (CIBC, TD, Scotiabank, CST Industries, LottoGopher roles; no dates) · 2026-09-24